MCP‐1 (CCL2) protects human neurons and astrocytes from NMDA or HIV‐tat‐induced apoptosis
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Acquired immunodeficiency syndrome (AIDS)‐associated dementia is often characterized by chronic inflammation, with infected macrophage infiltration of the CNS resulting in the production of human immunodeficiency virus type 1 (HIV‐1) products, including tat, and neurotoxins that contribute to neuronal loss. In addition to their established role in leukocyte recruitment and activation, we identified an additional role for chemokines in the CNS. Monocyte chemoattractant protein‐1 (MCP‐1 or CCL2) and regulated upon activation normal T cell expressed and secreted (RANTES) were found to protect mixed cultures of human neurons and astrocytes from tat or NMDA‐induced apoptosis. Neuronal and astrocytic apoptosis in these cultures was significantly inhibited by co‐treatment with MCP‐1 or RANTES but not IP‐10. The protective effect of RANTES was blocked by antibodies to MCP‐1, indicating that RANTES protection is mediated by the induction of MCP‐1. The NMDA blocker, MK801, also abolished the toxic effects of both tat and NMDA. Tat or NMDA treatment of mixed cultures for 24 h resulted in increased extracellular glutamate ([Glu]e) and NMDA receptor 1 (NMDAR1) expression, potential contributors to apoptosis. Co‐treatment with MCP‐1 inhibited tat and NMDA‐induced increases in [Glu]e and NMDAR1, and also reduced the levels and number of neurons containing intracellular tat. These data indicate that MCP‐1 may play a novel role as a protective agent against the toxic effects of glutamate and tat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Dong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., & Wong-Staal, F. (1990) · Nature · doi:10.1038/345084a0 · Cited by 896
Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V, Gendelman, R., Morgan, R. A., Wingfield, P., & Gallo, R. C. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.277-287.1993 · Cited by 796
Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity
Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., & Miller, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14500 · Cited by 692
Conant, K., Garzino-Demo, A., Nath, A., McArthur, J. C., Halliday, W., Power, C., Gallo, R. C., & Major, E. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3117 · Cited by 577
Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
Kaul, M., & Lipton, S. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8212 · Cited by 512
Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., & Tuohy, V. K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8472896 · Cited by 496
Chemokines and Their Receptors in the Central Nervous System
Bajetto, A., Bonavia, R., Barbero, S., Florio, T., & Schettini, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0214 · Cited by 416 · cited 2×
“In addition to leukocyte recruitment, chemokines also activate a variety of cellular responses, including cytokine production and axonal guidance and proliferation (Rollins 1997; Bajetto et al. 2001a,b).”
BackgroundMultifaceted Activities of the HIV-1 Transactivator of Transcription, Tat
Jeang, K.-T., Xiao, H., & Rich, E. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28837 · Cited by 414
Kruman, I. I., Nath, A., & Mattson, M. P. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6958 · Cited by 405
Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
Lipton, S. A., Sucher, N. J., Kaiser, P. K., & Dreyer, E. B. (1991) · Neuron · doi:10.1016/0896-6273(91)90079-f · Cited by 398
Expression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385 · cited 3×
“…and RANTES, through interactions with the CXCR4 and CCR5 receptors, respectively, induce low levels of apoptosis but are also protective against gp-120induced neurotoxicity because they compete for the same receptor (Meucci et al. 1998; Kaul and Lipton 1999; Meucci et al. 2000; Tong et al. 2000).”
BackgroundKarn, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3060 · Cited by 385
Liu, Y., Jones, M., Hingtgen, C. M., Bu, G., Laribee, N., Tanzi, R. E., Moir, R. D., Nath, A., & He, J. J. (2000) · Nature Medicine · doi:10.1038/82199 · Cited by 380
McManus, C., Berman, J. W., Brett, F. M., Staunton, H., Farrell, M., & Brosnan, C. F. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00002-2 · Cited by 380
Self-citationTransient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes
Nath, A., Conant, K., Chen, P., Scott, C., & Major, E. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17098 · Cited by 363
Glutamate release and neuronal damage in ischemia
Nishizawa, Y. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01142-0 · Cited by 363
Kelder, W., McArthur, J. C., Nance‐Sproson, T., McClernon, D., & Griffin, D. E. (1998) · Annals of Neurology · doi:10.1002/ana.410440521 · Cited by 338
Tumor Necrosis Factor α Inhibits Glutamate Uptake by Primary Human Astrocytes
Fine, S. M., Angel, R. A., Perry, S. W., Epstein, L. G., Rothstein, J. D., Dewhurst, S., & Gelbard, H. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15303 · Cited by 324
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1
Sabatier, J. M., Vives, E., Mabrouk, K., Benjouad, A., Rochat, H., Duval, A., Hue, B., & Bahraoui, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.961-967.1991 · Cited by 302
Xia, M. Q., Bacskai, B. J., Knowles, R. B., Qin, S. X., & Hyman, B. T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00285-x · Cited by 269
Nath, A., Haughey, N. J., Jones, M., Anderson, C., Bell, J. E., & Geiger, J. D. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200002)47:2<186::aid-ana8>3.0.co;2-3 · Cited by 267
Weiss, J. M., Nath, A., Major, E. O., & Berman, J. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2953 · Cited by 265
Self-citationHIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity
Haughey, N. J., Nath, A., Mattson, M. P., Slevin, J. T., & Geiger, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00396.x · Cited by 258
Eugenín, E. A., Eckardt, D., Theis, M., Willecke, K., Bennett, M. V. L., & Sáez, J. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051634298 · Cited by 238
Apoptosis induced by HIV-1 infection of the central nervous system.
Shi, B., De Girolami, U., He, J., Wang, S., Lorenzo, A., Busciglio, J., & Gabuzda, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119002 · Cited by 227
Karpus, W. J., & Ransohoff, R. M. (1998) · PubMed · Cited by 224
Schecter, A. D., Rollins, B. J., Zhang, Y. J., Charo, I. F., Fallon, J. T., Rossikhina, M., Giesen, P. L. A., Nemerson, Y., & Taubman, M. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28568 · Cited by 223
Simpson, J., Rezaie, P., Newcombe, J., Cuzner, M. L., Male, D., & Woodroofe, M. N. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00274-5 · Cited by 215
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.026002133.x · Cited by 209
Coughlan, C. M., McManus, C. M., Sharron, M., Gao, Z.-Y., Murphy, D., Jaffer, S., Choe, W., Chen, W., Hesselgesser, J., Gaylord, H., et al. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00024-5 · Cited by 202
Eugenín, E. A., Brañes, M. C., Berman, J. W., & Sáez, J. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1320 · Cited by 201
Self-citationMa, M., & Nath, A. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2495-2499.1997 · Cited by 198
Haughey, N. J., Holden, C. P., Nath, A., & Geiger, J. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731363.x · Cited by 191
Karpus, W. J., & Ransohoff, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2667 · Cited by 189
Bajetto, A., Barbero, S., Bonavia, R., Piccioli, P., Pirani, P., Florio, T., & Schettini, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00350.x · Cited by 186
Weiss, J. M., Downie, S. A., Lyman, W. D., & Berman, J. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6896 · Cited by 186
Self-citationTong, N., Perry, S. W., Zhang, Q., James, H. J., Guo, H., Brooks, A., Bal, H., Kinnear, S. A., Fine, S., Epstein, L. G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1333 · Cited by 183
Kutsch, O., Oh, J.-W., Nath, A., & Benveniste, E. N. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9214-9221.2000 · Cited by 178
Kolb, S., Sporer, B., Lahrtz, F., Koedel, U., Pfister, H., & Fontana, A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00223-9 · Cited by 174
Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat
Rappaport, J., Joseph, J., Croul, S., Alexander, G., Valle, L. D., Amini, S., & Khalili, K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.458 · Cited by 171
Chemokine and Chemokine-Receptor Expression in Human Glial Elements
McManus, C. M., Weidenheim, K., Woodman, S. E., Nunez, J., Hesselgesser, J., Nath, A., & Berman, J. W. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65013-4 · Cited by 168
Self-citationTat Transactivation: A Model for the Regulation of Eukaryotic Transcriptional Elongation
Taube, R., Fujinaga, K., Wimmer, J., Barborič, M., & Peterlin, B. M. (1999) · Virology · doi:10.1006/viro.1999.9944 · Cited by 159
Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia
Thompson, K. A., McArthur, J. C., & Wesselingh, S. L. (2001) · Annals of Neurology · doi:10.1002/ana.1011 · Cited by 143
Conant, K. E., Ma, M., Nath, A., & Major, E. O. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1384-1389.1996 · Cited by 134
Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia
Pender, M. P., & Rist, M. J. (2001) · Glia · doi:10.1002/glia.1103 · Cited by 134
Chemokine receptors in the human brain and their relationship to HIV infection
Lavi, E., Kolson, D. L., Ulrich, A. M., Fu, L., & González‐Scarano, F. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114531 · Cited by 133
Intracellular Trafficking and Interactions of the HIV-1 Tat Protein
Stauber, R. H., & Pavlakis, G. N. (1998) · Virology · doi:10.1006/viro.1998.9400 · Cited by 132
HIV-1 Tat Causes Apoptotic Death and Calcium Homeostasis Alterations in Rat Neurons
Bonavia, R., Bajetto, A., Barbero, S., Albini, A., Noonan, D. M., & Schettini, G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5743 · Cited by 125
HIV-Tat Protein Activates c-Jun N-Terminal Kinase and Activator Protein-1
Kumar, A., Manna, S. K., Dhawan, S., & Aggarwal, B. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.776 · Cited by 120
Bruno, V., Copani, A., Besong, G. E., Scoto, G. M., & Nicoletti, F. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00367-8 · Cited by 118
Little, A. R., Benkovic, S. A., Miller, D. B., & O'Callaghan, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00359-7 · Cited by 103
Dreyer, E. B., & Lipton, S. A. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01048.x · Cited by 100
CD40-CD40L Interactions Induce Chemokine Expression by Human Microglia
D’Aversa, T. G., Weidenheim, K. M., & Berman, J. W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64875-4 · Cited by 97
Self-citationVesce, S., Bezzi, P., Rossi, D., Meldolesi, J., & Volterra, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00674-1 · Cited by 91
Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms
Macho, A., Calzado, M. A., Jiménez‐Reina, L., Ceballos, E., n, J. L., & Muñoz, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203095 · Cited by 78
Prendergast, M., Rogers, D. T., Mulholland, P. J., Littleton, J. M., Wilkins, L. H., Self, R. L., & Nath, A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03360-7 · Cited by 75
Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes
Woodman, S. E., Benveniste, E. N., Nath, A., & Berman, J. W. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909021296 · Cited by 66
Self-citationNishida, K., Markey, S. P., Kustova, Y., Morse, H. C., Skolnick, P., Basile, A. S., & Sei, Y. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010433.x · Cited by 41
Milani, D., Zauli, G., Neri, L. M., Marchisio, M., Previati, M., & Capitani, S. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-12-2587 · Cited by 40
Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis
Iarlori, C., Reale, M., Luca, G. D., Iorio, A. D., Feliciani, C., Tulli, A., Conti, P., Gambi, D., & Lugaresi, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00487-8 · Cited by 27
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Cited by
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639
“Additionally, the Berman group at Einstein College of Medicine has shown numerous effects of CCL2 onHIV-infectedmacrophages [200, 228].”
BackgroundDelivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Whitney, N. P., Eidem, T. M., Peng, H., Huang, Y., & Zheng, J. C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05886.x · Cited by 373
Metadata
- Authors
- Eugenin, E. A., D'Aversa, T. G., Lopez, L., Calderon, T. M., & Berman, J. W.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2003-05-14
- Volume
- 85
- Issue
- 5
- Pages
- 1299-1311
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1576120369
- Cited by
- 288
- References
- 65
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.